CMS Exempt • FDA Cleared

Revolutionize Wound Care with Omeza OCM™

The only advanced wound matrix exempt from the 2026 CMS pricing cap. While competitors are limited to $127.14/cm², OCM™ maintains full $2,050/vial reimbursement — giving your practice unmatched clinical outcomes and financial stability.

See Clinical Results Calculate Your ROI
$2,050
Per Vial Reimbursement
100%
CMS Exempt Status
4-Phase
Comprehensive Healing
A2014
CMS Code

Critical Industry Update

As of January 1, 2026, most advanced skin substitutes are capped at $127.14/cm² under new CMS regulations. Omeza OCM™ remains fully exempt, preserving your practice's revenue and your patients' access to the most advanced care.

Why OCM™ Changes Everything

The Complete Wound Healing Solution

OCM™ (Omeza Complete Matrix) is the first and only drug-device combination product that addresses all phases of wound healing — from biofilm reduction to complete tissue regeneration. It's not just different. It's better.

Reduce Biofilm Impact

OCM™ actively inhibits biofilm formation, addressing one of the primary causes of chronic wound stasis.

  • Antimicrobial properties
  • Prevents infection escalation
  • Reduces treatment time

Decrease Inflammation

Pharmaceutical-grade omega-3 peptides provide targeted anti-inflammatory action directly in the wound bed.

  • Cold water fish peptides
  • Time-released delivery
  • Pain reduction

Support Complete Healing

Unlike single-action products, OCM™ supports proliferation, remodeling, and epithelialization for complete wound closure.

  • Scaffolding for tissue growth
  • Absorbable & biodegradable
  • Proven clinical outcomes

The Reimbursement Advantage That Changes Your Practice

While the entire wound care industry faces dramatic reimbursement cuts, OCM™ offers financial protection and clinical superiority.

Most Advanced Skin Substitutes

$127.14
Per cm² (CMS 2026 Cap)
  • Severely limited reimbursement
  • Reduced profit margins
  • Potential access barriers
CMS Exempt

Omeza OCM™

$2,050
Per Vial (Carrier-Priced)
  • Full reimbursement preserved
  • Practice revenue protected
  • Superior clinical outcomes
Proven Clinical Outcomes

Real Patients, Real Healing

See the transformative power of OCM™ through documented case studies. These are real wound healing progressions from practicing clinicians using Omeza Complete Matrix in their protocols.

54-Year-Old Male with Chronic Venous Leg Ulcer

152+ Days Non-Healing
HTN, Factor V Leiden
Chronic venous leg ulcer before OCM treatment

Before Treatment

Day 0 - Chronic non-healing wound

Healed venous leg ulcer after OCM treatment

After OCM™

Week 12 - Complete epithelialization

12
Weeks to Heal
4
OCM™ Applications
100%
Closure Rate

Patient presented with a long-standing venous stasis ulcer that had failed previous silver and amnion products. After the first two OCM™ treatments, robust granulation tissue formed. Over the next three applications, the wound quickly epithelialized and achieved complete closure.

"What intrigued me most was the presence and benefit of the Omega-3's. After the first two treatments, I was most impressed by the positive qualitative change to the wound bed with robust granulation tissue forming. Over the next three treatments, the wound quickly epithelialized and was healed."

ML
Dr. Michael Lacqua, MD MBA

Medical Director, The Center for Wound Healing, Richmond University Medical Center

67-Year-Old Diabetic with Chronic Foot Ulcer

90+ Days Non-Healing
Type 2 Diabetes, PVD
Diabetic foot ulcer before OCM treatment

Before Treatment

Day 0 - Stalled diabetic foot ulcer

Healed diabetic foot ulcer after OCM treatment

After OCM™

Week 10 - Wound closure achieved

10
Weeks to Heal
3
OCM™ Applications
100%
Closure Rate

This diabetic foot ulcer had stalled for over three months with conventional treatment protocols. OCM™ was applied after sharp debridement. Within one week post-application, significant reduction in edema and wound size was observed with increased epithelialization. Complete healing was achieved after three applications.

"When I used OCM™ on one of my patients, after one week post application, I noticed a significant reduction in edema, wound size and increased epithelialization. Before using Omeza, the patient's wound had stalled in healing, and this amazing product definitely helped kickstart the healing process. After about three months of using Omeza, I can finally say my patient's wound is healed."

OR
Oscar Rojas, DPM

Barry University Foot and Ankle Institute, Miami, FL

Ready to Achieve These Results in Your Practice?

Join hundreds of wound care providers who are transforming patient outcomes with OCM™. Our team will provide complete clinical training and reimbursement support to ensure your success.

Request a Clinical Representative

Calculate Your Practice Revenue Potential

See exactly how much revenue OCM™ can generate for your practice. Adjust the sliders below based on your patient volume.

25 patients
2 vials per treatment cycle

Monthly Revenue

$102,500
Gross reimbursement

Annual Revenue

$1,230,000
Projected yearly total

Vials Per Month

50
Total product volume

Revenue Breakdown

Vial Reimbursement (CMS A2014) $2,050
Avg. Vials Per Patient 2
Revenue Per Patient $4,100
Patients Treated Monthly 25

Calculator Assumptions

  • Based on CMS reimbursement code A2014 at $2,050/vial
  • OCM™ is exempt from 2026 CMS pricing cap (most competitors capped at $127.14/cm²)
  • Actual vials per patient varies by wound size and treatment protocol
  • Reimbursement may vary by payer; Medicare rates shown
  • Does not include additional CPT code reimbursements for application

Ready to Transform Your Wound Care Practice?

Speak directly with your dedicated Omeza specialist to learn how OCM™ can enhance patient outcomes, protect your revenue, and position your practice at the forefront of advanced wound care.

Ben Barton - Your Omeza Representative

Ben Barton

Your Wound Care Specialist

(843) 708-6364
Available Now

OR EMAIL US